SynthesisInflammopharmacology2025

Efficacy and safety of Mirikizumab in the treatment of moderate to severe inflammatory bowel diseases: a systematic review and updated meta-analysis.

Joel Gabin Konlack Mekontso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.